Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
24HrDoc Review
A telehealth service selling compounded semaglutide and tirzepatide. The FDA reviewed its website in December 2025 and issued a warning letter in February 2026 over false or misleading claims about those exact products — which is where any honest review has to start.
24HrDoc
FDA Warning Letter24HrDoc is a telehealth platform offering compounded semaglutide and tirzepatide for weight management alongside a broader online medical service. It is aimed at cash-pay patients wanting a straightforward online route to a GLP-1 prescription.
The finding that governs this review: on 20 February 2026 the FDA issued 24HrDoc, Inc. a warning letter — reference 717984 — after reviewing the company's website in December 2025. The agency found the site offered compounded drug products including semaglutide and tirzepatide with false or misleading claims about them. That is a federal regulator concluding that how this company described its medication to patients was misleading, and it concerns precisely the products you would be buying.
For fairness: a warning letter of this kind concerns marketing claims, not a finding that a specific batch was contaminated or underdosed, and 24HrDoc was one of many operations caught in a large enforcement programme — roughly 80 letters in September 2025, around 30 on 3 March 2026 and 25 more in June 2026. Companies commonly correct the language and continue trading. Around a dozen providers reviewed on this site carry one.
What we could not do is offset that with anything verifiable. We were unable to confirm pricing, plan structure, state coverage, refund terms, lab requirements or the compounding pharmacy from the public site, and found no independent review record of any substance. A provider with a regulatory finding against it and nothing checkable in its favour is a difficult recommendation to make.
Affiliate disclosure: GLP1Drugs.org may earn a commission if you sign up through the links on this page. It has not changed our rating, which is among the lower ones on this site, and it has not stopped us leading with the FDA letter. Checked 7 August 2026.
Visit 24HrDocOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
Feb 2026
FDA Warning Letter
717984
Letter Reference
0
FDA-Approved Products
—
Pricing We Could Verify
FDA warning letter issued to 24HrDoc, Inc. dba 24HrDoc on 20 February 2026, following a December 2025 review of the company's website.
The FDA Warning Letter
| Element | Detail |
|---|---|
| Recipient | 24HrDoc, Inc. dba 24HrDoc |
| Date and reference | 20 February 2026, letter 717984 |
| What triggered it | The FDA reviewed 24hrdoc.com in December 2025 and observed the site offering compounded drug products including semaglutide and tirzepatide |
| The allegation | False or misleading claims concerning those compounded semaglutide and tirzepatide products |
| Wider context | Part of a sustained FDA programme: roughly 80 letters in September 2025, around 30 on 3 March 2026, and 25 more in June 2026 |
Our consistent position on these letters: they are about what a company told patients, not proof that a particular vial was defective, and a company that corrects the language deserves credit for it. But when the whole transaction rests on trusting an online seller's description of an unapproved medicine, a regulator having formally found that description misleading is exactly the kind of thing a buyer should weigh. Read our brand versus compounded guide for what the FDA has been objecting to across the category.
What's Offered
Compounded Semaglutide
The active ingredient in Ozempic and Wegovy, in compounded form — not FDA-approved and not equivalent to the branded product
Compounded Tirzepatide
The dual GIP/GLP-1 agonist found in Mounjaro and Zepbound, again compounded
Online Prescriptions
A telehealth intake with prescriptions issued by licensed providers if treatment is judged appropriate
Flexible Plans
The company advertises personalised prescriptions and flexible plan options
Home Delivery
Medication shipped directly rather than collected from a pharmacy
Broader Telehealth
24HrDoc operates as a general telehealth service, with weight management one line among several
Pros & Cons
Pros
- ✓Offers both semaglutide and tirzepatide rather than only one molecule
- ✓A conventional telehealth intake with prescribing by licensed providers
- ✓Operates as a broader telehealth service rather than a single-product storefront
- ✓Home delivery, with no pharmacy visit required
Cons
- ✕The FDA issued 24HrDoc a warning letter on 20 February 2026 over false or misleading claims about its compounded semaglutide and tirzepatide
- ✕The FDA reviewed the company's website in December 2025 and found the claims there in breach
- ✕Compounded medication is not FDA-approved and has not been through the trials the category's marketing relies on
- ✕We could not verify pricing, plan structure, state coverage, refund terms or lab requirements at source
- ✕No compounding pharmacy is named that we could find
- ✕No independent review record of any substance surfaced in our research
How It Works
Read The Warning Letter First
Before anything else, read what the FDA actually said. It is public, it is short, and it concerns the specific products this company sells.
Online Intake
Complete the telehealth questionnaire covering weight history, conditions and current medications.
Provider Review
A licensed provider reviews your information and decides whether to prescribe. Prescribing is never guaranteed.
Ask The Sourcing Questions
Which pharmacy fills the order, is it 503A or 503B, and what clinical basis supports compounding in your case now that neither drug is in shortage.
Get Terms In Writing
Pricing, renewal price, cancellation and refund terms. We could not verify any of these from the public site.
Eligibility, Limitations & Alternatives
Eligibility and limitations
- —United States; state coverage not verified — confirm yours at intake
- —Pricing, membership fees, refund terms and lab requirements not verifiable at source
- —Compounding pharmacy not named; no insurance route identified
- ✕Not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
- ✕Not in pregnancy, when trying to conceive, or while breastfeeding
Better-documented alternatives
- •Amazon One Medical — FDA-approved medication from $149 cash, $25 insured, no compounding
- •Trimi Health — $99 semaglutide, $125 tirzepatide, flat at every dose, no FDA letter
- •Cora Health — all-inclusive from $99, two named PCAB-accredited pharmacies
- •Compounded providers without FDA letters
Our Verdict
2.7 / 5 — a functioning telehealth service offering both GLP-1 molecules, but carrying a February 2026 FDA warning letter over false or misleading claims about those exact products, with essentially nothing verifiable on the other side of the ledger.
24HrDoc appears to be a real telehealth operation with licensed providers, offering both compounded semaglutide and compounded tirzepatide with home delivery, as part of a broader online medical service. Nothing we found suggests it is a fake pharmacy, and the FDA letter concerns marketing language rather than a finding about a specific batch.
But we rate what a buyer is realistically taking on. Here that is an unapproved compounded medication from a company a federal regulator has formally told to correct how it describes those medications — and we could not verify a single price, plan term, refund policy, state list or pharmacy partner to weigh against it. Providers we rate well above this offer $99–$129 a month with no FDA letter, named pharmacies and published terms, and an approved product is now available for $149 cash through a route with no regulatory findings at all. There is nothing on offer here that you cannot get from a provider with a cleaner record. If you are an existing customer receiving medication reliably, nothing here says stop — but ask the sourcing questions, and get your renewal price in writing.
Check 24HrDocFrequently Asked Questions
Did 24HrDoc really receive an FDA warning letter?
Yes. The FDA issued a warning letter to 24HrDoc, Inc. dba 24HrDoc, reference 717984, dated 20 February 2026. The agency reviewed the company's website at 24hrdoc.com in December 2025 and found that it offered compounded drug products, including semaglutide and tirzepatide, alongside false or misleading claims about them. That is a formal regulatory finding about the exact products this company sells, published by the FDA, and it is the single most important fact on this page. 24HrDoc was one of a large number of telehealth operations to receive letters in this enforcement wave — the FDA sent roughly 80 in September 2025, around 30 more on 3 March 2026, and a further 25 in June 2026.
What is the FDA actually objecting to?
Across this enforcement programme the recurring allegation is consistent: marketing that implies a compounded product is equivalent to, or is, an FDA-approved drug. The specific claims cited vary by company — describing compounded semaglutide as 'FDA-approved', saying it contains 'the same active ingredient as Ozempic' in a way that implies equivalence, printing the telehealth brand's own logo on medication labels so it appears the company compounded the drug itself, or attributing the branded products' clinical trial results to a compounded copy. Compounded drugs are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality, so claims of that kind render the products misbranded.
Does a warning letter mean the medication is dangerous?
Not by itself, and it would be unfair to say otherwise. These letters concern marketing claims rather than findings that a particular batch was contaminated or underdosed. Many recipients correct the language and carry on trading. What a warning letter does tell you is that a federal regulator examined how this company described its products to patients and concluded the description was false or misleading — which is directly relevant when the thing you are being asked to judge is whether you can trust what the company tells you. Around a dozen providers reviewed on this site carry one, and we rate all of them below providers that do not.
What does 24HrDoc cost?
We could not verify pricing at source. The company advertises personalised prescriptions and flexible plans, but we were unable to confirm specific figures, plan tiers, membership fees, renewal pricing or what is included from the public site during our research. That is itself a finding worth reporting: in a category where the gap between advertised and actual price is the most common complaint, a provider whose pricing we cannot establish is one you should press hard for written figures before paying anything. Ask specifically what you will be charged in month three at the dose you are likely to be on.
Are the medications FDA-approved?
No. 24HrDoc dispenses compounded semaglutide and compounded tirzepatide. Compounded medications are prepared by licensed pharmacies for patient-specific prescriptions; they are not FDA-approved, are not evaluated by the FDA for safety, effectiveness or quality, and are not equivalent to Ozempic, Wegovy, Mounjaro or Zepbound beyond sharing an active ingredient. Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025, so ask what clinical basis supports compounding in your particular case.
Is there a better option?
For most people, yes. If an FDA-approved product is within reach — through insurance, a manufacturer programme, or a cash route such as Amazon's, which lists approved oral GLP-1s from $149/month — that is a better proposition than a compounded copy from a company with a regulatory finding against it. If you specifically want compounded medication at a low price, several providers we rate considerably higher offer $99–$129/month with no FDA letter, named pharmacies and published refund terms. There is no feature here that is unavailable elsewhere from a provider with a cleaner record.
Who should not use these medications?
GLP-1 receptor agonists are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in anyone who has had a serious allergic reaction to the medication. They should not be used in pregnancy, while trying to conceive, or while breastfeeding. Common side effects are nausea, vomiting, diarrhoea and constipation, usually worst during dose escalation; more serious risks include pancreatitis, gallbladder disease and kidney injury. Anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, diabetic retinopathy or kidney impairment should raise it specifically. This page is information, not medical advice.
If You Are Considering It
Read the FDA letter first, get pricing and refund terms in writing before paying, and ask which pharmacy fills your order and what clinical basis supports compounding in your case.
Visit 24HrDocCompare Other GLP-1 Providers
See how other telehealth providers stack up.
CoreAge Rx
#1 RecommendedFlat-rate pricing for compounded semaglutide and tirzepatide with NABP-verified pharmacies
Read Review →Amazon One Medical
Brand-Name, No CompoundingFDA-approved Wegovy, Zepbound and Foundayo from $149/month cash, $25 with insurance and $50/month for eligible Medicare members — the first mainstream route to approved medication at prices that compete with compounded. We earn no commission from it
Read Review →Boston Medical Group
Top RatedEstablished telehealth provider with physician oversight and transparent pricing
Read Review →PlushCare
Insurance AcceptedMajor telehealth platform with brand-name FDA-approved GLP-1s, insurance support, and 1M+ members treated
Read Review →Form Health
Comprehensive ProgramMultidisciplinary obesity medicine program with physicians, dietitians, and behavioral coaching
Read Review →JumpstartMD
Comprehensive ProgramMedically supervised program with obesity medicine physicians, dietitians, and in-person options
Read Review →Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing any treatment. Compounded medications are not FDA-approved, are not evaluated by the FDA for safety, effectiveness or quality, and are not equivalent to the branded drug beyond sharing an active ingredient. GLP-1 medications commonly cause nausea, vomiting, diarrhoea and constipation, and carry risks including pancreatitis, gallbladder disease and kidney injury; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and should not be used in pregnancy, when trying to conceive, or while breastfeeding. Prescribing is subject to clinician approval and is not guaranteed. Individual results vary and no outcome is promised.
Date reviewed: 7 August 2026. The FDA warning letter referenced is number 717984, issued to 24HrDoc, Inc. dba 24HrDoc on 20 February 2026 following an FDA review of the company's website in December 2025; it is published on fda.gov. A warning letter concerns the claims a company made and is not, by itself, a finding that any specific product was contaminated or misdosed, and companies may correct the cited language. We were unable to verify pricing, plan structure, membership fees, state coverage, refund terms, lab requirements or the compounding pharmacy from the public site, and have said so rather than inferring them. Confirm all terms directly with the provider before purchasing.
Affiliate Disclosure: This site may receive compensation from affiliate partners. This does not influence our editorial content or review ratings.